Related Experiment Videos
Circulating cytokines in Alzheimer's disease
1Department of Psychiatry, University of Michigan, School of Medicine, Ann Arbor 48108, USA. singhvk@umich.edu
Journal of Psychiatric Research
|February 3, 1998
Summary
Alzheimer's disease (AD) involves immune factors. This study found elevated interleukin-6 (IL-6) plasma levels in AD patients, indicating immune activation is linked to the neurodegenerative disease's progression.
Area of Science:
- Neuroimmunology
- Neurodegenerative Diseases
Background:
- Alzheimer's disease (AD) is a neurodegenerative disorder.
- Immune system activation is increasingly recognized as a potential factor in AD pathophysiology.
Purpose of the Study:
- To investigate the role of specific immune factors in Alzheimer's disease.
- To measure plasma levels of key cytokines in AD patients.
Main Methods:
- Plasma samples were collected from AD patients.
- Levels of four selective cytokines, including interleukin-6 (IL-6), interleukin-12 (IL-12), interferon-alpha (IFN-alpha), and interferon-gamma (IFN-gamma), were measured.
Main Results:
- Plasma levels of interleukin-6 (IL-6) were significantly elevated in AD patients compared to controls.
- No significant differences were observed in the plasma levels of IL-12, IFN-alpha, or IFN-gamma.
Conclusions:
- Elevated circulating IL-6 suggests immune activation is associated with Alzheimer's disease.
- These findings support the involvement of immune system dysregulation in AD pathogenesis.